Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vvax001 in HPV-16 Induced CIN3
NCT06015854Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2021
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
A Phase 2 trial of Vvax001 in cervical intraepithelial neoplasia (CIN), HPV16 infection (HPV16), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
Vvax001
03
Conditions
cervical intraepithelial neoplasia (CIN)HPV16 infection (HPV16)
Beyond the preview
Go deeper on NCT06015854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015854.